Edition:
United States

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

2.34USD
2:11pm EDT
Change (% chg)

$-0.03 (-1.27%)
Prev Close
$2.37
Open
$2.39
Day's High
$2.41
Day's Low
$2.34
Volume
1,360
Avg. Vol
28,474
52-wk High
$5.55
52-wk Low
$1.75

Chart for

About

OncoMed Pharmaceuticals, Inc. (OncoMed) is a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing therapeutics that address the fundamental biology driving cancer's growth, resistance, recurrence and metastasis. The Company's therapeutic candidates and preclinical programs include... (more)

Overall

Beta: 1.83
Market Cap(Mil.): $94.16
Shares Outstanding(Mil.): 38.43
Dividend: --
Yield (%): --

Financials

  OMED.OQ Industry Sector
P/E (TTM): -- 214.90 33.15
EPS (TTM): -0.61 -- --
ROI: -26.02 -3.85 13.23
ROE: -831.94 -5.38 15.27

BRIEF-Oncomed Reports Q1 Loss Per Share $0.15

* ONCOMED ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

May 08 2018

BRIEF-OncoMed Announces Appointment Of John Lewicki As CEO

* ONCOMED ANNOUNCES APPOINTMENT OF JOHN LEWICKI, PHD, AS PRESIDENT, CHIEF EXECUTIVE OFFICER AND A MEMBER OF THE BOARD OF DIRECTORS

Mar 19 2018

BRIEF-Oncomed Pharmaceuticals Reports Q4 Earnings Per Share $0.25

* ONCOMED PHARMACEUTICALS - CURRENT CASH IS ESTIMATED TO BE SUFFICIENT TO FUND OPERATIONS THROUGH AT LEAST Q3 OF 2019

Mar 08 2018

BRIEF-OncoMed Q4 Earnings Per Share $0.25

* ONCOMED ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Mar 08 2018

Competitors

  Price Chg
Amgen, Inc. (AMGN.OQ) $194.20 -0.68
Astellas Pharma Inc (4503.T) ¥1,810 +28.00
AstraZeneca plc (AZN.L) 5,551.00 +84.00
Bayer AG (BAYGn.DE) €93.41 +0.24
Bayer AG (BAYE.F) -- --
Celgene Corporation (CELG.OQ) $85.76 +0.53
Roche Holding Ltd. (ROG.S) CHF232.00 -0.25
Roche Holding Ltd. (RO.S) CHF236.80 +0.20
GlaxoSmithKline plc (GSK.L) 1,561.00 +2.80
Johnson & Johnson (JNJ.N) $128.93 +4.24

Earnings vs. Estimates